| dc.contributor.author | Malkan, U. | |
| dc.contributor.author | Buyukasik, Y. | |
| dc.contributor.author | Demiroglu, H. | |
| dc.contributor.author | Ciftciler, R. | |
| dc.contributor.author | Gunes, G. | |
| dc.contributor.author | Okay, M. | |
| dc.contributor.author | Goker, H. | |
| dc.date.accessioned | 2020-06-21T13:06:49Z | |
| dc.date.available | 2020-06-21T13:06:49Z | |
| dc.date.issued | 2018 | |
| dc.identifier.issn | 0145-2126 | |
| dc.identifier.issn | 1873-5835 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/11416 | |
| dc.description | 9th International Eurasian Hematology Oncology Congress (EHOC) -- OCT 17-20, 2018 -- Istanbul, TURKEY | en_US |
| dc.description | Ciftciler, Rafiye/0000-0001-5687-8531; Malkan, Umit Yavuz/0000-0001-5444-4895; Haznedaroglu, Ibrahim C./0000-0001-8028-9462 | en_US |
| dc.description | WOS: 000447176600134 | en_US |
| dc.description.abstract | … | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Pergamon-Elsevier Science Ltd | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Lenalidomide provide better progression free survival than thalidomide and bortezomib in the first relapse of multiple myeloma patients after autologous transplantation | en_US |
| dc.type | conferenceObject | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 73 | en_US |
| dc.identifier.startpage | S55 | en_US |
| dc.identifier.endpage | S56 | en_US |
| dc.relation.journal | Leukemia Research | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
